From the Congressional Budget Office (CBO), July 18, 2025.
CBO was asked to assess the effects of a permanent 10 percent reduction in NIH funding and a nine-month increase in FDA review times of new drug applications.
SUMMARY STATEMENT:
From the Congressional Budget Office (CBO), July 18, 2025.
CBO was asked to assess the effects of a permanent 10 percent reduction in NIH funding and a nine-month increase in FDA review times of new drug applications.
SUMMARY STATEMENT: